Department of Health and Human Services December 16, 2009 – Federal Register Recent Federal Regulation Documents

National Institute on Aging; Notice of Meeting
Document Number: E9-29902
Type: Notice
Date: 2009-12-16
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting
Document Number: E9-29901
Type: Notice
Date: 2009-12-16
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings
Document Number: E9-29900
Type: Notice
Date: 2009-12-16
Agency: Department of Health and Human Services, National Institutes of Health
Notice of Meeting: Secretary's Advisory Committee on Genetics, Health, and Society
Document Number: E9-29899
Type: Notice
Date: 2009-12-16
Agency: Department of Health and Human Services, Office of the Secretary
National Center for Complementary and Alternative Medicine; Notice of Meeting
Document Number: E9-29898
Type: Notice
Date: 2009-12-16
Agency: Department of Health and Human Services, National Institutes of Health
New Animal Drugs; Change of Sponsor; Ketamine
Document Number: E9-29888
Type: Rule
Date: 2009-12-16
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for an abbreviated new animal drug application (ANADA) for ketamine hydrochloride injectable solution from Bioniche Animal Health USA, Inc., to Bioniche Teoranta.
Implantation or Injectable Dosage Form New Animal Drugs; Florfenicol
Document Number: E9-29875
Type: Rule
Date: 2009-12-16
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Intervet, Inc. The supplemental NADA adds Mycoplasma bovis to the bovine respiratory disease pathogens for which florfenicol injectable solution is approved as a treatment.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.